Compound ID | 769
VRC-4219
Synonym(s): VRC 4219 | VRC4219
Class: Protein synthesis inhibitor
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Description: | Betacin antibiotic |
| Institute where first reported: | Veriscor (Pfizer, USA) |
| Year first mentioned: | 2001 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| Reason dropped: | Likely due to Vicuron programs being dropped by Pfizer after acquiring |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.